The briefing
The MHRA has limited certain over-the-counter nasal decongestant sprays containing xylometazoline or oxymetazoline to a maximum of five consecutive days. The safety update follows reported concerns and aims to reduce risks from prolonged use.
Original headline
Nasal decongestant spray use limited to five days